公开(公告)号：EP4393506A1

公开(公告)日：2024-07-03

申请号：EP22860563.0

申请日：2022-08-25

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

发明人： CHENG, Yanju ,  LI, Yingchun ,  KONG, Lingjie ,  GUO, Xiaolu ,  ZHAO, Wei

IPC分类号： A61K39/395 ,  C07K16/24 ,  A61K38/17 ,  C07K16/28 ,  A61P35/00 ,  A61P37/00

CPC分类号： A61K38/17 ,  A61K39/395 ,  A61P35/00 ,  A61P37/00 ,  C07K16/28 ,  C07K16/24

摘要： The present disclosure provides a pharmaceutical composition of an anti-IL4R antibody and a use thereof. The pharmaceutical composition comprises the anti-IL4R antibody or an antigen binding fragment thereof, and a buffering agent; and the pharmaceutical composition can further comprise a surfactant and a stabilizer.

公开(公告)号：EP4302778A1

公开(公告)日：2024-01-10

申请号：EP22762538.1

申请日：2022-03-02

申请人： CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.

发明人： KONG, Lingjie ,  CHENG, Yanju ,  GUO, Xiaolu

IPC分类号： A61K39/395 ,  C07K16/24 ,  C12N15/13 ,  A61P37/02

摘要： Provided are a pharmaceutical composition containing an anti-TSLP antibody, and a use thereof. In particular, provided are a pharmaceutical composition, containing (a) an anti-TSLP antibody, (b) a buffer, (c) a surfactant, and one or more (d) stabilizers, and a use of the pharmaceutical composition in preparation of a medicament for treating and preventing TSLP-related diseases.